ResearcherTUM KlinikumNo recent work listed
Clara Lubeseder–Martellato
Matched on ORCID iD 0000-0002-8360-5800; OpenAlex author ID A5082244223. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 38
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 2 papers
Papers 5
- Loss of Wasl improves pancreatic cancer outcome. Last author DOI 10.1172/jci.insight.127275↗
- Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. Co-author DOI 10.1172/jci.insight.137809↗
- Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. Co-author DOI 10.1016/j.ajpath.2016.07.025↗
- Membranous CD24 drives the epithelial phenotype of pancreatic cancer. Co-author DOI 10.18632/oncotarget.9402↗
- Early requirement of Rac1 in a mouse model of pancreatic cancer. First author DOI 10.1053/j.gastro.2011.04.043↗
Closest collaborators
The 25 strongest of 38 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Roland Michael Schmid · 5 shared papers, 2011–2020 · strength 0.28
- Paper Loss of Wasl improves pancreatic cancer outcome. DOI 10.1172/jci.insight.127275↗
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Jens Thomas Siveke · 5 shared papers, 2011–2020 · strength 0.28
- Paper Loss of Wasl improves pancreatic cancer outcome. DOI 10.1172/jci.insight.127275↗
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Guido von Figura · 3 shared papers, 2016–2020 · strength 0.21
- Paper Loss of Wasl improves pancreatic cancer outcome. DOI 10.1172/jci.insight.127275↗
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Maximilian Reichert · 3 shared papers, 2016–2020 · strength 0.20
- Paper Loss of Wasl improves pancreatic cancer outcome. DOI 10.1172/jci.insight.127275↗
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- Paper Membranous CD24 drives the epithelial phenotype of pancreatic cancer. DOI 10.18632/oncotarget.9402↗
- Ana Hidalgo‐Sastre · 3 shared papers, 2016–2020 · strength 0.19
- Paper Loss of Wasl improves pancreatic cancer outcome. DOI 10.1172/jci.insight.127275↗
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Paper Membranous CD24 drives the epithelial phenotype of pancreatic cancer. DOI 10.18632/oncotarget.9402↗
- Zahra Dantes · 2 shared papers, 2020 · strength 0.15
- Roland Rad · 2 shared papers, 2020 · strength 0.15
- Irina Heid · 3 shared papers, 2011–2020 · strength 0.15
- Paper Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. DOI 10.1172/jci.insight.137809↗
- Paper Membranous CD24 drives the epithelial phenotype of pancreatic cancer. DOI 10.18632/oncotarget.9402↗
- Paper Early requirement of Rac1 in a mouse model of pancreatic cancer. DOI 10.1053/j.gastro.2011.04.043↗
- Bence Sipos · 3 shared papers, 2011–2016 · strength 0.13
- Paper Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model. DOI 10.1016/j.ajpath.2016.07.025↗
- Paper Membranous CD24 drives the epithelial phenotype of pancreatic cancer. DOI 10.18632/oncotarget.9402↗
- Paper Early requirement of Rac1 in a mouse model of pancreatic cancer. DOI 10.1053/j.gastro.2011.04.043↗
- Günter Schneider · 2 shared papers, 2016–2020 · strength 0.12
- Rickmer Braren · 2 shared papers, 2016–2020 · strength 0.12
- Matthias Wirth · 2 shared papers, 2016–2020 · strength 0.12
- Marina Lesina · 2 shared papers, 2011–2020 · strength 0.12
- Henrik Einwächter · 1 shared paper, 2020 · strength 0.09
- Lucia Liotta · 1 shared paper, 2020 · strength 0.07
- Katja Peschke · 1 shared paper, 2020 · strength 0.07
- Marc Eric Martignoni · 1 shared paper, 2020 · strength 0.07
- Karin Feldmann · 1 shared paper, 2020 · strength 0.07
- Helmut Frieß · 1 shared paper, 2020 · strength 0.07
- Wilko Weichert · 1 shared paper, 2020 · strength 0.07
- Georgios A. Kaissis · 1 shared paper, 2020 · strength 0.07
- Alexander Hennig · 1 shared paper, 2020 · strength 0.07
- Alexander Muckenhuber · 1 shared paper, 2020 · strength 0.07
- Felix Orben · 1 shared paper, 2020 · strength 0.07
- Aristeidis Papargyriou · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.